FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy
The U.S. Food and Drug Administration (FDA) has approved the extension of
Now, keeping your hair during chemo is up to you.
NoteData shown are approximate and may vary depending on individual factors and the different chemotherapy regimens used, such as Cyclophosphamide, Daunorubicin, Docetaxel (Taxotere), Doxorubicin, Paclitaxel (Taxol) and others. For more detailed and specific information on the effectiveness of scalp cooling with different drugs, please refer to specialised studies.
As the management of the side effects of chemotherapy becomes a priority in the field of oncology, research into treatments such as scalp cooling and cryocompression for chemotherapy-induced peripheral neuropathy has become essential.
In this section, you will find a variety of articles exploring the latest developments and leading research on the use of cryogenic caps.
These studies and publications provide detailed and up-to-date information on the efficacy, applications and benefits of this innovative technique to mitigate hair loss and other side effects during chemotherapy treatment.
Estimated hair loss without scalp cooling (without cap):
That is, out of every 100 patients on your type of chemotherapy, approximately XX% experience significant hair loss.
Estimation of hair loss with scalp cooling (with cap):
That is, out of every 100 patients using scalp cooling, hair is retained in a remarkable XX% of cases.
This data has been analysed and compiled from several dozen scientific studies and articles published in prestigious journals. Using state-of-the-art artificial intelligence, the results have been processed and combined to provide an accurate and up-to-date picture of the likelihood of hair loss in chemotherapy treatments.
The use of cooling caps may not be appropriate for certain types of cancer or chemotherapy treatments, such as leukaemias and lymphomas. In patients with metastases to the scalp or any area of the head (including the skull and meninges), the decision on the use of cooling should be assessed on an individual basis and always under the supervision of a specialised medical team.
Here you will find published scientific studies, carefully analysed, translated and interpreted using artificial intelligence to facilitate their understanding and application in the management of the side effects of chemotherapy.
The U.S. Food and Drug Administration (FDA) has approved the extension of
Introduction Chemotherapy-induced alopecia (CIA) is a common and emotionally distressing side effect for cancer patients.
Introduction The article addresses one of the most distressing side effects of chemotherapy: induced alopecia. The loss of
Introduction Scalp cooling has been used since the 1970s to mitigate chemotherapy-induced alopecia.
Introduction: The gel hair cooling cap is a tool used to prevent hair loss in patients with hair loss.
Document Analysis Method: In today's digital era, artificial intelligence (AI) has transformed the way in which we
Scalp cooling caps are an effective tool to reduce hair loss during treatments.
The 1980 scalp cooling cap patent introduced an innovative solution to reduce alopecia in patients undergoing chemotherapy. This cap uses cooling technology to decrease blood flow to the hair follicles during treatment, thus minimising hair loss. Its anatomical design and high quality materials ensure comfort and efficacy, improving patients' quality of life and emotional well-being.
Introduction Scalp cooling has been used to mitigate chemotherapy-induced alopecia (CIA), but there is little evidence to suggest that it can be used to treat this condition.
Introduction: Scalp cooling is the only method available to prevent chemotherapy-induced alopecia (CIA). Although
Scalp cooling caps have become a useful tool to reduce hair loss.
Introduction Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of chemotherapy treatment.
Introduction Chemotherapy-induced alopecia is a side effect that can have a significant emotional impact on patients.
Introduction The study «Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Receiving Chemotherapy: A Prospective Multicenter Study of Breast Cancer Patients Receiving Chemotherapy: A Prospective Multicenter Study of
Choosing a scalp cooling cap during chemotherapy is a decision that impacts physical well-being.
A cooling cap is a specially designed device that is placed on the scalp to keep the scalp cool during the cooling period.
Hair loss is one of the most visible and emotional side effects of chemotherapy, and it can affect
The Princess of Wales, Kate Middleton, paid a visit to the Royal Marsden Hospital in London, where she received cancer treatment at the Royal Marsden Hospital.
